It has been reported that sustained DDIT4 overexpression, inhibits mTORC1, but activates mTORC2-mediated Akt phosphorylation, a key survival signal, ultimately promoting tumor cell survival and chemoresistance [54]. The gene discussed is AKT1; the disease is neoplasm.